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Background: Stroke is a leading cause of disability. Nonetheless, the care pathway
for stroke rehabilitation takes partially into account the needs of chronic patients.
This is due in part to the lack of evidence about the mechanisms of recovery after
stroke, together with the poor knowledge of related and influencing factors. Here we
report on the study protocol “Rehabilitation and Biomarkers of Stroke Recovery,” which
consists of 7 work-packages and mainly aim to investigate the effects of long-term
neurorehabilitation on stroke patients and to define a related profile of (clinical-biological,
imaging, neurophysiological, and genetic-molecular) biomarkers of long-term recovery
after stroke. The work-package 1 will represent the main part of this protocol and aims
to compare the long-term effects of intensive self-rehabilitation vs. usual (rehabilitation)
care for stroke.
Methods: We planned to include a total of 134 adult subacute stroke patients (no
more than 3 months since onset) suffering from multidomain disability as a consequence
of first-ever unilateral ischemic stroke. Eligible participants will be randomly assigned
to one of the following groups: intensive self-rehabilitation (based on the principles of
“Guided Self-Rehabilitation Contract”) vs. usual care (routine practice). Treatment will
last 1 year, and patients will be evaluated every 3 months according to their clinical
presentation. The following outcomes will be considered in the main work-package:
Fugl-Meyer assessment, Cognitive Oxford Screen Barthel Index, structural and functional
neuroimaging, cortical excitability, and motor and somatosensory evoked potentials.
Discussion: This trial will deal with the effects of an intensive self-management
rehabilitation protocol and a related set of biomarkers. It will also investigate the role
of training intensity on long-term recovery after stroke. In addition, it will define a
set of biomarkers related to post-stroke recovery and neurorehabilitation outcome
in order to detect patients with greater potential and define long-term individualized
rehabilitation programs.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT04323501.
Keywords: clinical neurophysiology, cognition, microbiota, microRNAs, movement, oxidative stress, psychology,
prognosis
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INTRODUCTION
Stroke is a leading cause of death worldwide with an incidence
of 150–300/100,000 per year. Despite the improvements in
prevention and treatment of the acute phase, stroke remains
the main cause of adult disability in Western Countries, with
40% of stroke survivors reporting problems in activities of daily
living (1, 2). Currently, in Italy there are over one million
people suffering from long-term disability after stroke (3).
Nonetheless, the care pathway for stroke rehabilitation focuses
mainly on the first period (a few weeks or a few months)
after acute stroke, taking partially into account the needs of
patients during the (short- and long-term) chronic phase. This
is further stressed by the difficult access to rehabilitation and
care after discharge. In our view this organizational model is
also due to the lack of evidence about the mechanisms of
recovery in the subacute and chronic phases of stroke together
with the poor knowledge of related and influencing factors
(3). Along these lines, within the framework of multidomain
disability (sensorimotor, cognitive-behavioral, autonomic, and
psychosocial) affecting patients with stroke it is necessary to
define a number of clinical, functional, neurophysiological,
neuroimaging, genetic-molecular, and psychological factors that
correlate prospectively with long-term recovery and disability
after stroke. This is in order to describe a profile of biomarkers
that characterizes stroke patients with greater recovery potential,
on which to base the development of innovative treatment
protocols for long-term rehabilitation (4–8).
Here, we report the protocol of the study “Rehabilitation
and biomarkers of stroke recovery” (ClinicalTrials.gov identifier
NCT04323501), which is a single blind, randomized, controlled
(parallel-group) trial consisting of seven work packages (WP).
Its aim is to investigate the effects of a treatment protocol based
on self-management for long-term neuromotor rehabilitation
of stroke patients and to define a related profile of clinical-
biological, imaging, neurophysiological, and genetic-molecular
biomarkers of long-term recovery after stroke.
WP1 represents the interventional part of this protocol and
compares the long-term effects of intensive self-rehabilitation
vs. the usual rehabilitation care for patients with chronic
stroke. Furthermore, it aims to define a set of neuroimaging
(diffusion tensor imaging and functional magnetic resonance
imaging) and neurophysiological biomarkers (motor evoked
potentials and intracortical excitability measured by single and
paired transcranial magnetic stimulation, somatosensory
evoked potentials, and brain connectivity measured by
electroencephalographic phase synchrony) related to the
long-term outcome of neuromotor rehabilitation. WP2 aims
to investigate cognitive plasticity mechanisms related to
neuromotor recovery after long-term rehabilitation in patients
with stroke. WP3 explores fatigue, body composition and
walking issues in relation with long-term rehabilitation outcome
after stroke. WP4 aims to define some psychological aspects,
including distress, pain, and motivation, related to the long-
term rehabilitation process and post-stroke outcome. WP5,
WP6, and WP7 aim, respectively, to describe some issues
about microbiota, microRNA expression, and oxidative stress
phenomena associated with the mechanisms of post-stroke
recovery in relation to long-term rehabilitation management (9).
METHODS AND MATERIALS
The study will be conducted at the Department of Neurosciences,
Biomedicine, and Movement of Verona, University in
Verona, Italy.
Participants
As to eligibility for this protocol, the inclusion criteria are
the following: age >18 years; multidomain disability as a
consequence of first-ever unilateral ischemic stroke documented
by computerized tomography scan or magnetic resonance
imaging; and nomore than 3months since stroke onset; ability of
patient and/or caregiver to understand the instructions provided
for self-rehabilitation. Exclusion criteria are the following:
inclusion in other trials; Mini Mental State Examination
score <24/30 (10); drug addiction; and other neurological or
orthopedic conditions limiting the inclusion in this protocol.
Further eligibility criteria for WP2 are cognitive disability with
adequate comprehension skills (people with limited attention
span excluded). As to other additional eligibility criteria, WP3
will include patients with stroke who are able to walk and
have adequate comprehension skills once they have reached the
chronic phase of illness. An extra eligibility criterion for WP4 is
the presence of painful conditions. The study does not include
vulnerable populations such as prisoners, legally interdicted
persons, or institutionalized people.
Recruitment
Subjects will be recruited among consecutive patients referring
to the Neurorehabilitation Unit of the University Hospital of
Verona in Italy. All participants will have to give their informed
written consent to participate in the study.
Randomization, Allocation Concealment,
and Blinding
Prior to testing, eligible participants are randomly assigned in
a 1:1 ratio to one of the two interventions of WP1: intensive
self-rehabilitation (Group 1) vs. usual rehabilitation care (Group
2). The patients will be allocated to one of the two intervention
arms according to a balanced (restricted) software-generated
randomization scheme. Once the decision has been made, the
investigator, who has determined whether a subject is eligible for
the trial, is unaware of which group the subject would be allocated
to (with the allocation contained in opaque sealed envelopes).
Another investigator will check for correct patient allocation
according to the randomization list. Investigators who assess
outcomes are blinded to the intervention performed.
Interventions
Both types of interventions will last 1 year.
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Self-Rehabilitation
Patients allocated to this group will undergo an intensive self-
rehabilitation protocol based on the principles of “Guided Self-
Rehabilitation Contract” (11, 12). This approach consists of
an antagonist-targeting self-rehabilitation treatment supported
by a diary and based on a moral contract between patient
and therapist. In particular, therapists will define, teach, and
readjust over time a daily program of self-stretch postures and
training exercises according to the needs and progress of each
patient. Furthermore, the therapist will provide each patient
with an illustrated manual that describes the training program.
The stretching program involves static postures of stretching
at a high load below the pain threshold for specific antagonist
muscle groups; tension on the stretched muscles should be
kept for a cumulative period of ≥10min a day per targeted
muscle. The training program includes a series of unassisted
rapid alternating movements (or movement efforts) of possible
maximum amplitude against targeted antagonist muscles in a
short time (e.g., 15–30 s per series, depending on fatigability). At
each visit a diary will be requested from the patient reporting
the actual practice of self-treatment (e.g., daily time, number
of repetitions).
Usual Rehabilitation Care
In this group, physiotherapy sessions will be freely prescribed
by the patient’s physiatrist, according to the usual care practice,
which take into account not only medical opinions but also
the patient’s needs and requests. This community-based therapy
sessions are universally and indefinitely covered by the public
National Health System in Italy. Physiotherapists providing
rehabilitation sessions in this group will be freely selected
by the patient and/or recommended by the physiatrist, as in
routine practice.
Outcomes
The primary endpoint of WP1 is comparison of sensorimotor
disability after self-rehabilitation vs. usual care treatment.
Accordingly, its primary outcome is Fugl-Meyer assessment
(FMA), which comprises five domains (155 items in total) as
follows: motor function of the upper and lower extremities;
sensation, tested through a light touch on two surfaces of the
arm and leg, as well as position sense for eight joints; balance,
three seated and four standing tests; joint range of motion, testing
eight joints; and joint pain. Items are scored on the basis of ability
to complete the item, according to which 0 = cannot perform;
1 = performs partially; and 2 = performs fully. The maximum
total scale score is 226. Points are divided among the domains
as follows: the motor function score ranges from 0 (hemiplegia)
to 100 points (normal motor performance) and is divided into
66 points for the upper extremities and 34 points for the lower
extremities; the sensation score ranges from 0 to 24 points and is
divided into 8 points for light touch and 16 points for position
sense; the balance score ranges from 0 to 14 points and is divided
into 6 points for sitting and 8 points for standing; the joint range
of motion and pain scores range from 0 to 44 points (13).
The secondary endpoint of WP1 is comparison of cognitive
and global disability after self-rehabilitation vs. usual care
treatment. Accordingly, its secondary outcomes are the Cognitive
Oxford Screen (OCS) and the Barthel Index (BI). The OCS
is structured on five cognitive domains (namely, attention and
executive function, language, memory, number processing, and
praxis) and consists of 12 tasks as follows: picture naming (score
range 0–4); semantics (score range 0–3); orientation (score range
0–4); visual field (score range 0–4); sentence reading (score range
0–15); number writing (score range 0–3); calculation (range score
0–4); broken hearts (range score 0–50); imitation (range score 0–
12); recall and recognition (range score 0–4 each); and executive
task (range score 0–13). The cutoffs are adjusted for age, gender,
and years of education (14). The BI measures the extent to
which somebody can function independently and has mobility
in their activities of daily living (i.e., feeding, bathing, grooming,
dressing, bowel control, bladder control, toileting, chair transfer,
ambulation, and stair climbing). The score ranges from 0 to
100 (15). Other factors considered in the WP1 will be structural
and functional neuroimaging, cortical excitability, motor, and
somatosensory evoked potentials.
Evaluation endpoints of WP2 include the ability to process
visual-spatial information consciously or unconsciously by
means of reaction times and to allocate selective attention to the
environment around the patient; the ability to perceive relevant
elements for behavioral attitudes bymeans of eyemovements and
to transform sensory information into appropriate movements,
in both a reactive and a predictive way. Accordingly, the
outcomes include behavioral measures—e.g., reaction times, eye
movements and limbmovements—and instrumental measures—
e.g., cortical excitability and cortical connectivity—assessed
by means of paired transcranial magnetic stimulation and
electroencephalographic phase synchrony.
The evaluation endpoints of WP3 include the measurements
of fatigue, body composition, and gait. Accordingly, the
outcomes include the Multidimensional Fatigue Inventory,
which aims to measure the frequency and severity of global
fatigue, with a score ranging from 0 to 100, and to define the type
of physical/muscular and mental fatigue (16). Other measures
include body densitometry (DEXA), walking energetics,
and mechanics.
Evaluation endpoints of WP4 include incidence of
psychopathology (e.g., anxiety and depression) after stroke
and related pain conditions, psychopathological issues, and
coping strategies affecting adherence to rehabilitation programs,
effectiveness of psychopharmacological and psychotherapeutic
treatments in stroke patients, definition of specific psychological
interventions supporting rehabilitation (17, 18). Accordingly,
the outcomes considered are the Symptom Checklist-90 scale
(19); the Eysenck Personality Questionnaire-R (20); the COPE
scale (21); the General Self-Efficacy Scale (22); the Acceptance
and Action Questionnaire-II scale (23); the Multidimensional
Scale of Perceived Social Support (24); the Brief Pain Inventory-I
scale (25).
The main endpoint of WP5 is to evaluate changes in
microbiota related to post-stroke condition and recovery.
Accordingly, the gut microbiota (GM) composition and changes
will be evaluated at different time points. To identify bacterial
species, present in GM, analysis of nine variable regions of
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16S ribosomal RNA gene will be performed by next generation
sequencing (NGS). Bioinformatical and statistical analyses will
be conducted to relate gut microbiota signatures at different
taxonomic levels to stroke rehabilitation conditions (25).
The main endpoint of WP6 is to evaluate the expression
of microRNAs (miRNAs) related to post-stroke condition and
recovery. Accordingly, in this study, the expression levels of
circulating miRNAs (miR-9; miR-29a- 3p; miR-155-5p; miR-
124; miR-146a; miR-210; miR-371-3p; miR-495-3p; miR-941;
spike-in) will be analyzed at different time points starting from
serum samples.
The main endpoint of WP7 is to evaluate the relationship
between stroke, oxidative stress, and neuronal death issues.
Accordingly, the following concentrations will be analyzed
at different time points starting from plasma samples:
glutathione disulphide ratio [GSH]/[GSSG]; nitrite/nitrate ratio
[NO2−]/[NO3−]; and post-translational oxidative modifications
of plasma proteins. Furthermore, the activation of STAT1
signaling will be evaluated in Peripheral Blood Mononuclear
Cells (PBMC).
Evaluation time points for all WPs are reported in Table 1.
Sample Size
We estimated that 88 subjects, 44 patients per group, would
provide 80% power (α level 5%) to detect a difference of 7 points
(SD 11.6) on the FMA, the primary outcome, between the groups
(26). Considering a dropout rate of 10%, we planned to enroll a
total of 97 patients in this study.
Data Analysis
Adequate descriptive statistics will be produced, including
frequency, mean, median, standard deviation, interquartile
range, and confidence intervals, for the demographic data
and outcome measures at each time point. As to WP1, the
comparison between groups, in terms of self-rehabilitation vs.
usual care, with regard to the outcomes considered at each
time point of the various evaluation times, will be performed
using parametric (e.g., t-test, ANOVA) and/or non-parametric
statistics, such as the Kruskal-Wallis test or the Mann-Whitney
test, depending on the data distribution. Correlation and
regression analyses will also be performed between neuroimaging
data, neurophysiological variables, and clinical outcomes at
different time points. As to the other WPs (2–7), comparisons
between groups at different times will be assessed using
parametric tests, such as the Student t-test and ANOVA,
or non-parametric tests, such as the Kruskal-Wallis test and
Mann-Whitney test, depending on the data distribution. For
each variable considered, both longitudinally and transversely,
correlation and regression analyses will also be performed.
Moreover, for each WP we will perform longitudinal intragroup
comparisons at different times by means of parametric tests, such
as the t-test and ANOVA and/or non-parametric tests, such as
the Friedman test and the Wilcoxon test, depending on data
distribution. The statistical analysis will be performed using the
Statistical Package for Social Science SPSS R© version 26.0 software
for Macintosh (SPSS Inc., Chicago, IL, USA). For all statistical
tests, the significance level is set at p < 0.05.
DISCUSSION
This trial will evaluate and follow up stroke patients from
subacute stroke to the chronic phase, up to 1 year after
stroke onset. It will deal with the effects of an intensive
self-management rehabilitation protocol and a related set of
biomarkers. In our view it will add some important pieces of
evidence to overcome current conceptual limitations on long-
term recovery models, upon which the usual care pathway
of stroke rehabilitation is based. Another aspect that will be
investigated by this study is the role of training intensity on
long-term recovery after stroke, a point that will be further
strengthened by the moral contract between patients and
therapists (12). As suggested in the literature, intensity is a
key element of stroke rehabilitation in order to achieve greater
training effects (2, 27). In addition, a pattern of biomarkers
related to post-stroke recovery and neurorehabilitation outcome
will be useful to detect those patients with greater potential
for recovery. Despite the fact that some of these biomarkers
have been previously reported to offer information on stroke
rehabilitation outcome, the prognostic relevance of their
combination has never been explored to date and may be
important for defining future long-term personalized medical
rehabilitation programs. The possible main problems concerning
the conduct of the study will be the number of patients
enrolling, this being a single center study, the long follow-up
duration (1 year), and the multifactorial/multimodal approach
to evaluate patients; (that is, many different outcomes will
be considered).
Ethics and Dissemination
Ethics, Privacy, Data Security, and Safety
This study has been approved (approval number 2320CESC)
by the local Ethics Committee (Comitato Etico per la
Sperimentazione Clinica delle Province di Verona e Rovigo)
and will be carried out according to the Declaration of
Helsinki. All data and biological samples collected during
the study will be handled fairly. The database will remain
strictly confidential, anonymized, password protected, and
stored together with biological samples in locked and secured
facilities at the Department of Neuroscience, Biomedicine, and
Movement Sciences of Verona University. Participants will sign
an informed consent form and will be assigned with a unique
anonymous identifier. Only authorized study personnel will
have access to the match between the identifier and identity
of patients. The identifier of each patient will remain the same
during the whole study and will allow the proper handling
of data and biological samples. Data will be collected in a
dedicated case report form and added to an electronic database
for analysis.
Dissemination Policy
A dissemination plan will be established during the first phase of
the study in agreement with all researchers by means of dedicated
meetings. The dissemination target will be different stakeholders
(e.g., other researchers, representatives and associations of
patients, healthcare professionals, and the general population).
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TABLE 1 | Evaluation time points.
T0◦ T1◦ T2◦ T3◦ T4◦
First week 3 months 6 months 9 months 12 months
Informed consent ✓
Inclusion and exclusion criteria ✓
Clinical history ✓
Fugl-Meyer Assessment ✓ ✓ ✓ ✓ ✓
Oxford Cognitive Screen ✓ ✓ ✓ ✓ ✓
Barthel Index ✓ ✓ ✓ ✓ ✓
Volumetric analysis of the stroke ✓
Side and site of stroke ✓
DTI ✓
fMRI ✓ ✓






Biochemistry and miRNA analysis ✓ ✓
Usual care ✓ ✓ ✓ ✓ ✓
Intensive self-rehabilitation program ✓ ✓ ✓ ✓ ✓
Physiatric evaluation ✓ ✓ ✓ ✓ ✓
Video analysis and energetic cost of the gait ✓ ✓ ✓ ✓ ✓
Psychological evaluation scales ✓ ✓ ✓ ✓ ✓
Informed consent ✓ ✓ ✓ ✓ ✓
DTI, Diffusion Tensor Imaging; fMRI, functional Magnetic Resonance Image; MEP, Motor evoked potential; SEP, Somatosensory evoked potential; TMS, Transcranial Magnetic Stimulation;
EEG, Electroencephalography; MFI, Multidimensional Fatigue Inventory; DEXA, Dual X-ray Absorptiometry; miRNA, microRNA. ◦Time from the enrollment.
Each dissemination product will be tailored to these different
target groups in terms of objectives, methods, timeline, and
language. Websites and social networks will also be used to
disseminate the project issues. The use of these social media
channels will allow a broader dissemination of the study
results. The scientific community will be reached through
scientific publications in national and international (preferably
open access) journals as well as by means of presentations
(keynotes and posters) at national and international congresses.
Items for dissemination in any format including publications
will not contain information leading to the identification
of patients.
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